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ABSTRACT  1 
Green tea catechins (GTC) reduce ultraviolet radiation (UVR)-induced inflammation in 2 
experimental models but human studies are scarce, and their cutaneous bioavailability and 3 
mechanism of photoprotection are unknown.  We aimed to examine oral GTC cutaneous 4 
uptake, ability to protect human skin against erythema induced by a UVR dose-range, and 5 
impact on potent cyclooxygenase and lipoxygenase-produced mediators of UVR-6 
inflammation, prostaglandin (PG)E2 and 12-hydroxyeicosatetraenoic acid (HETE), 7 
respectively.  In an open oral intervention study, 16 healthy humans (phototype I/II) were 8 
given low-dose GTC (540 mg) with vitamin C (50 mg) daily for 12 weeks. Pre- and post-9 
supplementation, buttock skin was exposed to UVR and resultant erythema quantified. Skin 10 
blister fluid and biopsies were taken from unexposed and UVR-exposed skin 24h-post a pro-11 
inflammatory UVR challenge (3 minimal erythema doses). Urine, skin tissue and fluid were 12 
analysed for catechin content, and skin fluid for PGE2 and 12-HETE, by liquid 13 
chromatography coupled to tandem mass spectrometry.  Fourteen completing subjects were 14 
supplement-compliant (12F, median 42.5y, range 29-59y). Benzoic acid levels were 15 
increased in skin fluid post-supplementation (P=0.03), and methylated gallic acid and several 16 
intact catechins and hydroxyphenyl-valerolactones were detected in skin tissue and fluid. 17 
Area-under-curve analysis for UVR-erythema revealed reduced response post-GTC 18 
(P=0.037). Pre-supplementation, PGE2 and 12-HETE were UVR-induced (P=0.003, 19 
P=0.0001). After GTC, UVR-induced 12-HETE reduced from mean±SD 64±42 to 41±32 20 
pg/L (P=0.01) while PGE2 was unaltered.  Thus GTC intake results in incorporation of 21 
catechin metabolites in human skin associated with abrogated UVR-induced 12-HETE; this 22 
may contribute to protection against sunburn inflammation and potentially longer-term UVR-23 
mediated damage.   24 
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INTRODUCTION 25 
Ultraviolet radiation (UVR) in sunlight is a key environmental stressor impacting on skin 26 
health. Acute effects include sunburn (an inflammatory response), immune-suppression and 27 
photosensitivity, while repeated exposures lead to photoageing and photocarcinogenesis 
(1)
. 28 
Sunburn is characterised clinically by erythema due to vasodilatation, and histologically a 29 
dermal infiltrate of neutrophils and mononuclear cells is observed 
(2, 3)
. Activation of 30 
cutaneous phospholipase (PL) A2 by UVR is a key part of the inflammatory response, 31 
releasing membrane esterified fatty acids, including arachidonic acid that is subsequently 32 
metabolised by cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome P450 (CYP) 33 
isozymes to produce eicosanoids with vasodilatory and chemoattractant properties (
4
). Potent 34 
pro-inflammatory mediators prostaglandin (PG) E2 and 12- hydroxyeicosatetraenoic acid 35 
(HETE) are the most abundant eicosanoids at the peak of the sunburn response, correlating 36 
with UVR-upregulated expression of COX-2 and 12-LOX in human skin 
(4)
. 37 
 The polyphenols are plant-derived molecules, many exhibiting anti-inflammatory 38 
properties 
(5, 6)
. Their oral intake is associated with health benefits including reduced risk of 39 
cancer and cardiovascular disease 
(7, 8)
. Studies performed largely in experimental models 40 
suggest polyphenols from various sources may protect skin against adverse effects of UVR, 41 
including carcinogenesis 
(1, 9, 10)
. Green tea is widely consumed worldwide and contains 42 
several polyphenols of the catechin family, i.e. green tea catechins (GTC), principally (-)-43 
epicatechin (EC), (-)-epicatechin-3-O-gallate (ECG), (-)-epigallocatechin (EGC) and (-)-44 
epigallocatechin-3-O-gallate (EGCG; 
11
). Emerging evidence suggests GTC can protect 45 
against cutaneous damage. Specifically, oral GTC protected against UVR-induced skin 46 
inflammation and carcinogenesis in hairless mice 
(12)
, whilst in humans, topically applied 47 
GTC reduced UVR-induced DNA damage, erythema and leucocytic infiltrate 
(13, 14)
, and oral 48 
green tea extract reduced skin erythema following a UVR challenge near the sunburn 49 
threshold 
(15)
. Some of these effects may be mediated via effects on COX and LOX isozymes, 50 
as EGCG, EGC, ECG and EC have been reported to reduce the production of PGE2 and/or 51 
12-HETE in experimental systems 
(16-18)
 and oral GTC to reduce UVR-induced COX-2 52 
protein expression and PGE2 production in mouse epidermis 
(10)
. However, it is unknown 53 
whether these findings have relevance to human skin.  54 
 Despite increasing evidence of their photoprotective potential, there is a dearth of 55 
information on cutaneous bioavailability of oral GTC in humans, reflecting the challenges of 56 
their tissue assessment. Moreover, the molecular mechanism(s) underlying protection from 57 
UVR-induced inflammation is unexplored in humans. Potentially this may be conveyed 58 
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through impact on key COX and LOX-derived pro-inflammatory eicosanoids mediating the 59 
sunburn response, which additionally exhibit promoting properties in skin carcinogenesis 
(4, 60 
19, 20)
. Thus, the aims of our novel study were to examine directly in humans in vivo for 61 
evidence of cutaneous uptake of orally administered GTC, to evaluate for impact of GTC on 62 
sunburn over a range of pro-inflammatory UVR doses, and explore whether the underlying 63 
mechanism of protection could be GTC modulation of PGE2 and/or 12-HETE formation.   64 
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METHODS 65 
Subjects and study design 66 
This was an open oral intervention study conducted in the Photobiology Unit, Dermatology 67 
Centre, Salford Royal NHS Foundation Hospital, Manchester, UK. Subjects (n=16) were 68 
white Caucasian males and females, sun-reactive skin type I-II (easy sunburn, minimal 69 
tanning). The exclusion criteria were: history of skin cancer or a photosensitivity disorder; 70 
use of a sunbed or sunbathing in the 3 months prior to the study, taking photoactive 71 
medication or nutritional supplements, consuming more than 2 cups of tea per day, and 72 
currently pregnant or breastfeeding. Ethical approval was obtained from the North 73 
Manchester Research Ethics Committee (reference 08/H1006/79). Written informed consent 74 
was obtained from the participants and the study adhered to Declaration of Helsinki 75 
principles.  76 
 77 
Dietary supplements 78 
Subjects took oral supplements comprising 540 mg GTC with 50 mg vitamin C, daily for 12 79 
weeks. These were in the form of 3 capsules each containing 450 mg green tea extract (total 80 
1350 mg tea, 540 mg GTC; Table 1) and 2 capsules each containing 25 mg vitamin C (total 81 
50 mg vitamin C), and were taken with breakfast each morning. The low dose vitamin C was 82 
added to stabilise the green tea extract in the gut lumen 
(21)
; oral vitamin C supplementation 83 
alone has been shown to have no impact on UVR-erythema 
(22)
. Supplements were provided 84 
by Nestec Ltd (Lausanne, Switzerland) and packaged by Laboratoire LPH (St Bonnet de 85 
Rochefort, France). Compliance was assessed by counting the residual capsules in the 86 
dispensed containers that volunteers were asked to return, and through analysis of 24 h urine 87 
samples collected from all volunteers pre and after 1 day, 6 weeks and 12 weeks 88 
supplementation. 89 
 90 
UVR exposure 91 
UVR exposures were performed using a solar simulator with emission of UVB and UVA 92 
mimicking that of sunlight (emission 290-400 nm; Newport Spectra-Physics Ltd). Irradiance 93 
of the light source was measured 10 cm from the source prior to each irradiation, using a 94 
radiometer (model IL 730A; International Light, USA) calibrated for use with the light 95 
source, to ensure consistency of doses applied. The minimal erythema dose (MED) of UVR 96 
of each subject was assessed at baseline and post-supplementation, following application of a 97 
geometric series of 10 doses of solar simulated UVR (erythemally weighted doses 6.6-68 98 
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mJ/cm
2
) to upper buttock skin (1 cm diameter circular sites). Irradiated sites were examined 99 
visually after 24 h, with the MED defined as the lowest dose producing visually discernible 100 
erythema. Erythema at each site was quantified as described in the following section. At 24 h 101 
prior to skin tissue and blister fluid sampling, doses of UVR of 3 x the individual’s pre-102 
supplementation MED were given to sites on one buttock; this does was selected in order to 103 
provoke an inflammatory response sufficient to significantly elevate cutaneous eicosanoid 104 
levels 
(4)
.     105 
 106 
Quantification of the UVR-induced erythemal responses 107 
The intensity of erythema (erythema index) was quantified using a reflectance instrument 108 
(Diastron) in n=10 subjects. Readings were taken in triplicate from each exposed site and 109 
from adjacent unexposed skin, and erythema expressed as the difference between these 110 
readings (E). Dose-response modelling was performed using a dedicated data analysis 111 
package (Regional Medical Physics Department, Gateshead & Tyneside Health Authority, 112 
UK) to calculate each subject’s D30, the UVR dose producing a E of 30 arbitrary units, a 113 
threshold value that approximates an individual’s visual MED. 114 
 115 
Skin biopsy and suction blister fluid sampling 116 
UVR-exposed (3 x MED) and -protected areas of upper buttock skin were sampled at 117 
baseline and post-supplementation; UVR exposures were limited to 1 buttock and the other 118 
buttock provided the unexposed skin and blister fluid samples. Skin punch biopsies (5 mm 119 
diameter) were taken after intradermal injection of lignocaine, as described 
(4)
, snap frozen 120 
and stored at -80°C. Suction blisters were raised using suctions cups with a central aperture 121 
diameter of 1 cm and vacuum of 250 mm Hg as described previously 
(4)
. Skin blister fluid 122 
was aspirated with a 23-gauge needle, snap frozen in liquid nitrogen and stored at -80
o
C until 123 
analysis. Samples destined for polyphenol analysis were combined with 25 µL NaH2PO4 (0.4 124 
mol/L, pH 3.6) containing 200 g/L ascorbic acid and 1 g/L EDTA, prior to freezing.  125 
 126 
Eicosanoid analysis  127 
Eicosanoids in skin blister fluid were analysed by liquid chromatography coupled to 128 
electrospray ionisation tandem mass spectrometry (LC/ESI-MS/MS) as described previously 129 
(23, 24)
. In summary, skin fluid samples (typically 50-200 μL) were diluted with methanol-130 
water (15% w/w) up to 3 mL. Internal standards (40 ng PGB2-d4 and 80 ng 12-HETE-d8; 131 
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Cayman Chemicals) were then added and resultant solutions acidified to pH 3.0, followed by 132 
solid-phase extraction (C18-E cartridges; Phenomenex) to reduce matrix effects and semi-133 
purify the lipid mediators. Eicosanoids were analysed on a C18 column (Luna 5 μm; 134 
Phenomenex) using a Waters Alliance 2695 HPLC pump coupled to a triple-quadrupole mass 135 
spectrometer equipped with an electrospray ionisation probe (Quattro Ultima, Waters). 136 
Instrument control and data acquisition were performed using MassLynx 4.0 software 137 
(Waters). The following multiple reaction monitoring (MRM) transitions were used for the 138 
assay: PGE2 m/z 351 > 271; 12-HETE m/z 319 >179. 139 
 140 
Polyphenol analysis of urine, skin tissue and blister fluid  141 
Urine was collected in HCl-washed flasks containing ascorbate (approx 1 g/L), and stored in 142 
aliquots at -80°C. Blister fluid and urine samples were enzymatically hydrolysed in line with 143 
previous literature 
(25)
, with adjustments. Following thawing at 5°C, urine was adjusted to pH 144 
5.0 with NaOH (0.1 mol/L). A 40 µL aliquot of urine or blister fluid was combined with 4 µL 145 
NaH2PO4 solution (0.4 mol/L, pH 5.0) containing 200 g/L ascorbic acid and 1 g/L EDTA, 20 146 
µL sodium acetate buffer (0.2 mol/L, pH 5.0) containing 0.012 µg taxifolin internal standard 147 
(Extrasynthese) and 5 U sulfatase (Type VIII, Sigma). Based on previous optimization work, 148 
100 U and 200 U β-glucuronidase (Type X, Sigma) in NaH2PO4 (75 mmol/L, pH 6.8) were 149 
added to blister and urine samples, respectively, and incubated at 37°C for 45 and 60 min 150 
respectively. Samples were extracted with 3 x 250 µL ethyl acetate, with vortexing and 151 
centrifugal separation at each step. The combined extracts were dried under nitrogen and 152 
frozen at -80°C. Samples and reagents were handled on ice throughout extraction. Dried 153 
samples were reconstituted with 12 µL 20% (v/v) acetonitrile containing 1 g/L ascorbic acid, 154 
and sealed in a micro-well plate before analysis. With the exception of hippuric acids (which 155 
were poorly partitioned into ethyl acetate), the average extraction efficiency for catechins and 156 
phenolic acids reported (Table 2) was 84.7 ± 13.0%, whilst internal standard extraction 157 
efficiency was consistently at 100%.  158 
Polyphenol-conjugates required extraction from biopsy tissue before enzyme 159 
hydrolysis. Additionally, Chu et al 
(26)
 highlighted problems using traditional 160 
ascorbate/EDTA solutions to stabilise catechins when handling tissue, owing to intrinsic iron 161 
content, and proposed the use of sodium dithionite, a reducing agent that does not take part in 162 
Fenton reactions. Biopsies were thawed at room temperature immediately before extraction 163 
then kept on ice throughout the procedure. Biopsies were washed in hexane to remove blood 164 
residue. A section of dermis was separated with a scalpel and weighed. To this, 250 µL 165 
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nitrogen-flushed chloroform containing 0.1 g/L butylated hydroxytoluene, and 250 µL 166 
sodium dithionite (0.3 mol/L) in sodium acetate buffer (0.2 mol/L, pH 5.0) were added. 167 
Samples were homogenized (Turrax micro homogenizer, IKA), with the sample being 168 
returned to ice at regular intervals, then vortexed and separated by centrifugation. The 169 
aqueous layer was removed and a second 250 µL aliquot of sodium dithionate in sodium 170 
acetate buffer added for a repeat extraction. Excess chloroform was removed via nitrogen 171 
drying, and the combined extracts mixed with 50 µL sodium acetate buffer (0.2 mol/L, pH 172 
5.0) containing 0.012 µg taxifolin internal standard, 10 U sulfatase and 200 U β-173 
glucuronidase. After 60 min incubation at 37
o
C the extraction proceeded as for blisters/urine, 174 
using 3 x 400 µL ethyl acetate.  175 
Samples were analysed using an Agilent 1200 SL HPLC system, which comprised a 176 
binary pump, degasser, well plate autosampler (5
o
C), and column oven (35
o
C) connected to a 177 
6410 triple quadrupole LC-MS/MS. A 5 µL aliquot was injected onto a Kinetex C18 178 
microbore column (2.6 µm, 150 x 2.1 mm; Phenomenex) running a binary gradient of LC-179 
MS grade water (Millipore) vs. acetonitrile (Fisher) both with 0.2% (v/v) formic acid, at 0.3 180 
mL/min. The gradient started at 5% acetonitrile for first 5.8 min, rose to 30% over 29.2 min, 181 
then increased to 95% acetonitrile over 2.4 min. This was held for a further 3.6 min to wash 182 
the column then returned to 5% acetonitrile over 3.6 min, re-equilibrating over a further 10.9 183 
min. The flow was passed into an electrospray source, with gas temperature 350
o
C, flowing 184 
at 11L/min, with a 30 psi nebulizer pressure. Analytes were detected in negative mode, using 185 
Dynamic MRM acquisition. Where available, analyte transmission and MS
2
 transition 186 
parameters were individually optimized using standards. Internal standards for EC, (+)-187 
catechin, EGC, ECG, EGCG and taxifolin were obtained from Extrasynthese. The retention 188 
times of gallocatechin, catechin gallate and gallocatechin gallate were determined by placing 189 
aqueous solutions of the relevant epi-isomers into a boiling water bath for 1 h. The 190 
chromatographic method did not distinguish between (+)- and (-)- enantiomers. The 3’ and 4’ 191 
mono-methylated forms of EC and EGC were obtained from Nacalai Tesque. Benzoic acid, 192 
3-hydoxy benzoic acid, hippuric acid, 3,4-dihydroxyphenylacetic acid, and 3-(2′,4′-193 
dihydroxyphenyl)propionic acid were obtained from Fluka and 4-hydroxy benzoic acid from 194 
Aldrich. Vanillic acid, 3,5 dihydroxy benzoic acid, gallic acid, syringic acid, 3- and 4- 195 
hydroxyphenyl acetic acids and 3-(3′-hydroxyphenyl)-propionic acid were obtained from 196 
Alfa Aesar. 3- and 4- methyl gallic acids were obtained from Apin Chemicals, and 2,4-197 
dihydroxy benzoic acid, 2,4,6-trihydroxy benzoic acid, 2-hydroxyphenyl acetic acid, and 2-198 
hydroxy hippuric acid from Acros Organics. All standards were of HPLC quality (>95% 199 
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purity). As commercial standards for hydroxyphenyl-valerolactones were not available, these 200 
were tentatively identified using previously reported MS
2
 fragment patterns 
(27)
. Analyte 201 
transmission and quantifying/qualifying MS
2
 transition parameters were individually 202 
optimized using repeat injections of extracted urine. A total of 3 hydroxyphenyl-203 
valerolactones were followed, namely 5-(3’,4’,5’-trihydroxyphenyl)-γ-valerolactone (M4; 204 
m/z 223 > 179+138), 5-(3’,4’-dihydroxyphenyl)-valerolactone (M6; m/z 207> 163+122) and 205 
5-(3’,5’-dihydroxyphenyl)-valerolactone (M6’: m/z 207> 163+123). M6 vs M6’ retention 206 
time was differentiated using a synthetic M6 standard 
(28)
, which was used to quantify all 207 
hydroxyphenyl-valerolactones. Following peak integration, peak areas were normalised to 208 
internal standard. Whilst response factors for hippuric and benzoic acids were low (on 209 
column limit of quantitation of 3.45 pmol and 50 pmol respectively) the universally high 210 
levels of these compounds in urine, skin fluid and tissue meant quantification was achievable. 211 
The average on column limit of quantitation for all other compounds was 380 fmol ± 365 212 
fmol.  213 
 214 
Statistical analysis 215 
Parametric data were tested using the paired t-test. The Wilcoxon signed rank test was used 216 
for data not satisfying assumptions of normality. Analyses were performed using StatsDirect 217 
(v2.7.7, StatsDirect Ltd.). Statistical significance was accepted at P < 0.05. Data are shown as 218 
mean ±SD and presented graphically as mean ±SEM.  219 
 220 
RESULTS 221 
Study subjects and compliance 222 
Of the 16 subjects recruited to the study, 1 withdrew before completion for reasons unrelated 223 
to the study. The supplement was well tolerated; 4 subjects reported mild nausea following its 224 
ingestion. Post-supplementation, all 4 major epicatechins and their metabolites were present 225 
in urine at day 1, week 6 and week 12, from 14 of the 15 subjects completing the study 226 
(Table 2).  Thus, 1 subject was non-compliant and 14 subjects (12 female) with a median age 227 
of 42.5 years (range 29-59) were included in study analyses.  228 
 229 
Urinary metabolites 230 
Of 35 tea phenolics and metabolites investigated, t-test analysis showed 20 components were 231 
significantly higher in week 12 urine samples compared to baseline (P < 0.05; n=13 due to 232 
absent record of one sample volume; Table 2), whilst 8 of these were consistently higher in 233 
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all participants. As well as several intact catechins, gallic acid and methylated metabolites, 234 
hydroxyphenyl-valerolactones, benzoic acid and its glycine conjugate, hippuric acid were all 235 
increased in urine following GTC consumption. Based on a daily intake of 129.2 mol of EC 236 
and 482.9 mol of EGC respectively, average urine excretion of all intact EC and EGC 237 
metabolites (including methylated forms) represented 6.1 and 7.1% of the dose, respectively.  238 
 239 
Skin uptake 240 
Skin fluid and biopsy (dermal) samples were taken from a subgroup of 10 participants at 241 
baseline and week 12, and subjected to qualitative analysis (Table 3). A total of 20 different 242 
phenolic compounds were observed in both sample types following supplementation. In 243 
blister fluid, hippuric, benzoic and 4-hydroxybenzoic acids were consistently present in all 10 244 
participants. Interestingly, methylated gallic acid and several intact catechins and catechin 245 
ring-fission products were also observed, with 4-O-methyl gallic acid present in half of the 246 
subjects, and EGC, M4 and M6 hydroxyphenyl-valerolactones observed in fluid from 2 247 
participants (Figure 1). Change from baseline was only statistically significant for benzoic 248 
acid (P = 0.03). Benzoic acid and its 4-hydroxylated form were also detected in all biopsy 249 
samples, whilst hippuric acid was only observed in 6 volunteers. Following supplementation, 250 
4’-O-methylated EGC (n=4), EGC (n=1), EC (n=2), EGCG (n=1) and 4-O-methyl gallic acid 251 
(n=2), were observed in the dermis of certain volunteers.  252 
 253 
UVR erythema dose-response 254 
The median MED was 35 mJ/cm
2
 at baseline and this was unchanged post-supplementation. 255 
Dose-response analysis showed a small increase in D30 from a mean ±SD of 28.0 ±7.7 256 
mJ/cm
2
 at baseline to 32.9 ±11.0 mJ/cm
2
 post supplementation although this did not reach 257 
statistical significance (P = 0.17). However, GTC supplementation resulted in a significant 258 
decrease in erythema at the maximum UVR dose given (68 mJ/cm
2
 erythemally weighted 259 
UVR) with E falling from 100.2 ±21.4 at baseline to 81.2 ±23.2 post-supplementation (P = 260 
0.006; Figure 2a). Area under curve analysis of the UVR-erythema dose-response showed a 261 
significant reduction in the erythema response post-supplementation (P = 0.037; Figure 2b). 262 
 263 
Production of PGE2 264 
Pre-supplementation, mean ±SD concentration of PGE2 in blister fluid from unexposed skin 265 
was 49.1 ±34.9 pg/µL. Production of PGE2 significantly increased by ~2.3-fold following 266 
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exposure to 3 x MED UVR (P = 0.003; Figure 3a). Post-supplementation, PGE2 in unexposed 267 
skin was similar to baseline (47.5 ±30.5 pg/µL). Exposure to the same UVR dose as at 268 
baseline produced a significant rise in PGE2 (~2.4-fold; P = 0.001), with no significant 269 
difference in PGE2 concentration between exposed skin at baseline and post-supplementation.  270 
 271 
Production of 12-HETE 272 
Pre-supplementation, the concentration of 12-HETE was significantly ~5-fold higher in 273 
UVR-exposed skin compared to unexposed skin (P = 0.0001).  Following supplementation, 274 
the UVR-induced rise in 12-HETE was ~2.7-fold (P = 0.004; Figure 3b), with significantly 275 
lower concentration of 12-HETE in UVR-exposed skin compared to baseline (P = 0.01), and 276 
no significance difference in unexposed skin. 277 
 278 
DISCUSSION 279 
This human oral intervention study is novel in several respects: it evaluates cutaneous uptake 280 
of catechins and catechin metabolites, measures the impact of low dose green tea 281 
supplementation on pro-inflammatory UVR challenges to the skin, and examines the 282 
potential for protection through reduction of pro-inflammatory eicosanoid production. Our 283 
data provide the first evidence that GTC can be taken up into the skin following oral intake in 284 
humans, and indicate their complex skin incorporation pattern. Significant reduction was 285 
found in the cutaneous UVR-erythema dose-response, with greatest effect at higher doses, 286 
and this reduced inflammation may be attributable to the associated significant abrogation of 287 
UVR-upregulation of the potent pro-inflammatory 12-LOX metabolite, 12-HETE. In 288 
contrast, no evidence was found for mediation of the protection conferred by GTC through an 289 
impact on the COX-2 metabolite PGE2. 290 
 The finding that GTC protect against UVR-induced erythema in humans is supported 291 
by previous studies of its topical application 
(13, 14)
 and a recent oral study 
(15)
. In the latter, 292 
volunteers consumed a green tea beverage providing a much higher dose of 1402 mg 293 
catechins/day for 12 weeks and this protected against the threshold erythema induced by the 294 
single UVR dose tested. We found a small (non-statistically significant) effect at the 295 
threshold value D30 and demonstrated how oral supplementation with GTC can protect 296 
against the inflammation produced over a range of higher UVR doses, such as can be 297 
achieved when individuals over-expose themselves to sunlight. Since one large cup of green 298 
tea (250 ml) contains approximately 300 mg of catechins (EC, ECG, EGC and EGCG) then 299 
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the modest level of GTC intake in our study, i.e. approximately 540 mg, is seen to be readily 300 
achievable in daily life, and this is already consumed in many parts of the world.  301 
Compliance with supplement ingestion was confirmed by demonstration of the 302 
urinary content of all four major categories of catechins in GTC, in all but one completing 303 
volunteer who was then excluded. As expected, the predominant intact catechins found in 304 
urine were not gallate esters, and the bioavailability of EC and EGC was in-line with reported 305 
studies 
(29, 30)
. GTC intervention resulted in a significant increase in the excretion of the 306 
majority of intact catechins from baseline at day 1, and throughout the 12-week study, with 307 
no apparent accumulation or adaptive response during this time. However, the excretion of 308 
several general polyphenol breakdown products, including hippuric, benzoic and syringic 309 
acids, were only significantly elevated from baseline after 12 weeks intervention. Hippuric 310 
acid has previously been reported as the primary urinary metabolite following both green and 311 
black tea intervention, with participants excreting 3.8 ±0.3 and 4.2 ±0.3 mmol/24 h 312 
respectively, following a 6g/day intervention with tea solids 
(31)
. Whilst hippuric acid was 313 
indeed the major urinary metabolite detected in our study (5.3 ±1.7 mmol/24 h post 314 
supplementation), its significant increase from baseline (at week 12) was only in the order of 315 
~30%. Hippuric acid is a terminal metabolite of benzoic acid, which itself is a colonic 316 
breakdown product common to various phenolic substances. Hippuric acid excretion is 317 
therefore not unique to GTC per se, and its use as a biomarker of catechin consumption in 318 
free-living populations is limited. Hydroxyphenyl-valerolactones are catechin metabolites 319 
produced by colonic ring fission: M4 and M6’ are predominantly derived from EGC, and M6 320 
from EC 
(27)
. Previously, Lee et al 
(30)
 reported M6 as accounting for 11.2% of EC dose in 8 321 
human subjects, although considerable variability was observed in M6 plasma levels. Urinary 322 
M4 was reported to account for just 1.4% of the EGC dose. In our study, M6 accounted for 323 
~24% of EC dose on average at week 12, with M4 and M6’ accounting for ~4% and ~3% of 324 
the EGC dose. Levels of hydroxyphenyl-valerolactone excretion were significantly increased 325 
compared to baseline at day 1 and throughout the 12 week intervention, without a significant 326 
change in the level of excretion between acute and chronic GTC consumption. Therefore, we 327 
propose that these compounds may therefore serve as a useful biomarker of EC and EGC 328 
intake, over both the short and long term.   329 
Detecting polyphenols and metabolites in tissues is a challenge since they bind to 330 
proteins, are at low levels and extraction methods are in development. We discovered that 331 
benzoic acid, its 4-hydroxyl form and its glycine-conjugate hippuric acid were typically 332 
present in both skin blister fluid and dermis. Wide inter-individual differences in oral 333 
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bioavailability and metabolism of polyphenols in foods are commonly reported 
(30, 32)
. 334 
Consistent with this, intact catechins, gallic acids and catechin ring-fission products were 335 
observed in the skin fluid and dermal samples of some, but not all volunteers following GTC 336 
supplementation. However, significant post-supplement increases in blister fluid benzoic acid 337 
content indicates that volunteers experienced an increase in polyphenol metabolites in the 338 
target area as a consequence of GTC intervention, at least partially derived from metabolism 339 
by colonic microflora. 340 
The reduced inflammatory response to UVR on GTC was associated with significant 341 
reduction in UVR-induction of the hydroxy fatty acid 12-HETE, the most abundant pro-342 
inflammatory eicosanoid induced in human skin by UVR exposure. As well as being a 343 
leucocyte chemoattractant, this potent keratinocyte-derived mediator has been shown to cause 344 
a dose-related erythema when applied to human skin in vivo 
(33)
. While more attention has 345 
focused on the role of PGE2 in mediating erythema, COX-2 inhibitors only partially suppress 346 
UVR-erythema whilst completely suppressing UVR-induced PGE2 
(34)
, and LOX-derived 347 
mediators could also contribute 
(35)
. Promotion of neutrophil and mononuclear cell migration 348 
into the dermis by 12-HETE may further augment the dermal vasodilatation and leucocytic 349 
infiltration through neutrophil release of vasodilatory nitric oxide, reactive oxygen species 350 
and chemokines 
(36)
. Other antioxidant and cell signalling activities of GTC may also 351 
contribute to reduction of UVR-inflammation 
(1, 9)
, including through modulation of 352 
transcription factor NF-κB (37), nitric oxide (19, 38) and reduced formation/enhanced repair of 353 
UVR-induced DNA damage 
(10, 14, 39)
.    354 
Our data indicate a direct effect of oral GTC on 12-LOX and/or possibly CYP 355 
isoforms producing 12-HETE following UVR, but not on COX-2 (Figure 4). This contrasts 356 
with studies in prostate and colon cancer cell lines, where the most abundant polyphenolic 357 
compound in tea, EGCG, inhibited protein and/or mRNA expression of COX-2 
(40, 41)
. 358 
However, EGCG, EGC and ECG are reported to inhibit LOX activity in colonic mucosa 
(16)
 359 
and EC to inhibit activity of human platelet 12-LOX 
(17)
. Topical green tea polyphenols (1-24 360 
mg in 200 µL acetone) in mice reduced the activity of both LOX and COX enzymes after 12-361 
O-tetradecanoylphorbol-13-acetate-induced tumour production, resulting in decreased PGE2 362 
and 12-HETE production 
(42)
. Differences in findings are not unexpected between 363 
experimental models and human skin in vivo, and the catechin dose applied might also 364 
influence outcomes 
(43, 44)
. 365 
Ultraviolet radiation is the principal aetiological factor in the majority of skin cancers, 366 
through its actions as a tumour-promoter, as well as an initiator of DNA damage that can lead 367 
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to mutagenesis, and repeated acute UVR insults to the skin are a risk factor for skin cancer 368 
development. Interestingly, 12-HETE is over-expressed in a variety of human tumours, 369 
including skin cancer, and it has tumour promoting ability which is thought to be conveyed 370 
by its anti-apoptotic and angiogenic properties 
(45, 46)
. Moreover, inhibitors of 12-HETE are 371 
successful in protecting against tumorigenesis in cancer cell lines 
(47)
. This adds to other 372 
evidence suggesting GTC may have potential for development as an effective and safe 373 
chemopreventive agent in humans, as in murine UVR-induced skin tumours 
(9)
.   374 
In summary, this work indicates that following oral ingestion, green tea catechin 375 
metabolites reach the skin target organ in humans, and that they suppress the biosynthesis of 376 
eicosanoid 12-HETE and sunburn erythema induced by pro-inflammatory UVR challenges.  377 
Manipulation of pro-inflammatory signalling pathways through supplementation with 378 
nutritional bioactives is an attractive strategy for photoprotection in humans, and may 379 
represent a complementary approach to topical sunscreens which are infrequently and 380 
generally poorly applied 
(48)
. Further studies are indicated to assess 12-LOX as a molecular 381 
target of oral GTC in human skin, alongside scrutiny for their potential longer-term 382 
photoprotective benefit.  383 
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TABLE 1 
Catechin and gallic acid content of green tea extract
1
  
GTC mg/450 mg capsule 
Gallic acid 0.4 ± 0.0 
Catechin 2.1 ± 0.0 
Epicatechin 12.5 ± 0.2 
Gallocatechin 12.4 ± 0.6 
Epigallocatechin 49.3 ± 3.9 
Catechin gallate 0.3 ± 0.0 
Epicatechin gallate 26.0 ± 0.2 
Gallocatechin gallate 4.5 ± 0.4 
Epigallocatechin gallate 72.6 ± 3.1 
Total 180.0 ± 8.3 
1
 Values are mean ±SD. Contents of 3 capsules were homogenized and extracted in triplicate.
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TABLE 2  
Green tea catechins and their metabolites significantly increased in urine post-
supplementation (n=13) 
 Amount excreted in urine (µmol) 
Compound Baseline Day One Week 6 Week 12 
 Mean SD Mean SD Mean SD Mean SD 
EC
1
 0.3 0.4 7
5
  
7 
 7± 
4 5
5
 4 7
5
 5 
3’-O-methyl EC1 0.06  0.08 0.65  0.3 0.55 0.4 0.65  0.3 
4’-O-methyl EC1 0.04 0.05 0.24  0.2 0.24 0.2 0.35 0.2 
ECG 0.000  0.002 0.01
5
  0.01 0.02
5
 0.01 0.01
4
  0.01 
EGC
1
 0.2 0.4 22
5
  13 20
5
  16 25
5
 20 
3’-O-methyl EGC1 
epigallocatechin*
†
 
0.01 0.04 0.2
5
  0.1 0.2
5
  0.2 0.2
5
  0.2 
4’-O-methyl EGC1 
epigallocatechin*
†
 
0 0 8
4
  8 8
4
  9 9
4
  8 
EGCG 0.00 0.01 0.06
5
  0.05 0.06
5
  0.04 0.08
4
 0.09 
Catechin 0.01 0.02 0.2
5
  0.1 0.1
5
  0.1 0.2
5
 0.2 
Gallocatechin 0 0 0.4
4
  0.5 0.3
3
  0.5 0.6
4
  0.6 
Gallocatechin gallate 0 0 0.003  0.00
9 
0  0 0.01
5
  0.02 
Gallic acid 0.6 0.7 1  1 0.7
3
 0.5 1
4
  1 
3-O-methyl gallic acid 0.6 0.6 1  1 0.9 0.8 1
3
 1 
3-hydroxybenzoic acid 1 1 2  2 2  3 4
3
 4 
M4 valerolactone
1,2
 0.3 0.4 30
4
  27 18
3
 25 21
4
 21 
M6’ valerolactone,2 0.5 0.7 184  16 124 13 154 15 
M6 valerolactone 10 12 33
4
  25 27
3
 28 31
3
  24 
Syringic acid 2 1 4 5 3 2 4
3
  4 
Benzoic acid 81 83 95 60 101 132 140
3
  120 
Hippuric acid 4000 2200 5100   2500 4300 1900 5300
3
  1700 
1
 Increased excretion of metabolite from baseline to week 12 in 100% of subjects 
2 M4 and M6’ hydroxyphenyl-valerolactone calculated as M6 equivalents 
3
 P < 0.001 (2-tailed paired t-test), from baseline 
4
 P < 0.01 (2-tailed paired t-test), from baseline 
5
 P < 0.05 (2-tailed paired t-test), from baseline 
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TABLE 3  
Presence of green tea catechins and their metabolites in skin blister fluid and tissue samples 
post-supplementation (week 12; n=10)
1
 
Compound 
Skin blister fluid Skin biopsy 
Change from 
average baseline 
value 
Detected in n 
participants 
Change from 
average baseline 
value 
Detected in n 
participants 
Benzoic acid +36%
2 
10 ND 10 
4-OH-benzoic acid ND 10 ND 10 
Hippuric acid ND 10 ND 6 
4-O-Me-gallic acid ND 5 ND 2 
EC - - PPS 2 
EGC PPS 2 PPS 1 
EGC-4-Me - - PPS 4 
EGCG - - PPS 1 
M4 valerolactone PPS 2 - - 
M6 valerolactone PPS 2 - - 
1
 Paired t-test performed only for compounds present in all subjects. EC, epicatechin; ECG, 
epicatechin-3-O-gallate; EGC, epigallocatechin; EGCG, epigallocatechin-3-O-gallate; ND, 
no significant difference; PPS, only present post-supplementation.  
2
 P = 0.03 (2-tailed paired t-test) compared with baseline. 
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FIGURE LEGENDS 
 
FIGURE 1. LC-MS/MS total ion current chromatogram of major compounds in skin fluid 
(A) and dermal skin tissue extract (B) post green tea catechin supplementation (week 12). 
Peak identities and multiple reaction monitoring m/z transitions are 1. M4 hydroxyphenyl-
valerolactone (223>179); 2. 4-hydroxybenzoic acid (137>93); 3. Hippuric acid (178>134); 4. 
2,4-dihydroxybenzoic acid (153>109); 5. M6 hydroxyphenyl-valerolactone (207>163); 6. 
Epicatechin (289>245); 7. 3-(3′-hydroxyphenyl)-propionic acid (165>121); 8. Benzoic acid 
(121>77). 
 
FIGURE 2. Impact of oral green tea catechins on UV radiation-induced erythema. Erythema 
response to solar simulated UV radiation at the D30 and the highest dose (68 mJ/cm
2
), pre and 
post 12 weeks supplementation (A). UV radiation-erythema dose-response curves pre 
(circles) and post (squares) 12 weeks supplementation (B). Data are mean ± SEM, n=10. *P < 
0.05, **P < 0.01 (2-tailed paired t-test). 
 
FIGURE 3. Concentration of PGE2 (A; n=10) and 12-HETE (B; n=14) in skin fluid from 
unexposed skin and skin exposed to 3 x MED solar simulated UVR both pre- and post-
supplementation for 12 weeks with green tea catechins. Data are mean ± SEM. *P < 0.05, 
**P < 0.01, ***P < 0.001 (2-tailed paired t-test for PGE2, Wilcoxon signed rank test for 12-
HETE). HETE, hydroxyeicosatetraenoic acid; MED, minimal erythema dose; PG, 
prostaglandin. 
 
FIGURE 4. Schematic to illustrate proposed mechanism of the impact of GTC and 
metabolites on UV radiation-induced 12-HETE production. COX, cyclooxygenase; cPLA2, 
cutaneous phospholipase A2; GTC, green tea catechins; HETE, hydroxyeicosatetraenoic acid; 
LOX, lipoxygenase. 
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